Home Healthcare Biotechnology Infectious Disease Molecular Diagnostics Market

Infectious Disease Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Services), By Applications (Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, HPV, Sexually Transmitted Infections, Sepsis, Drug Resistance Disease, Other Infectious Diseases), By Technology (Polymerase chain reaction (PCR), In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Chips and Microarrays, Mass Spectrometry, Sequencing, Transcription Mediated Amplification, Others), By End-User (Hospitals, Clinics, Diagnostics Laboratories, Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR5231DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Infectious Disease Molecular Diagnostics Market Size Analysis
    1. Introduction
    2. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Reagents
      3. Services
    3. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Respiratory Diseases
      2. Tuberculosis
      3. Meningitis
      4. Gastrointestinal Tract Infections
      5. HPV
      6. Sexually Transmitted Infections
      7. Sepsis
      8. Drug Resistance Disease
      9. Other Infectious Diseases
    4. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase chain reaction (PCR)
      2. In Situ Hybridization
      3. Isothermal Nucleic Acid Amplification Technology (INAAT)
      4. Chips and Microarrays
      5. Mass Spectrometry
      6. Sequencing
      7. Transcription Mediated Amplification
      8. Others
    5. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Diagnostics Laboratories
      4. Research Institutes
  7. North America Infectious Disease Molecular Diagnostics Market Size Analysis
    1. Introduction
    2. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Reagents
      3. Services
    3. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Respiratory Diseases
      2. Tuberculosis
      3. Meningitis
      4. Gastrointestinal Tract Infections
      5. HPV
      6. Sexually Transmitted Infections
      7. Sepsis
      8. Drug Resistance Disease
      9. Other Infectious Diseases
    4. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase chain reaction (PCR)
      2. In Situ Hybridization
      3. Isothermal Nucleic Acid Amplification Technology (INAAT)
      4. Chips and Microarrays
      5. Mass Spectrometry
      6. Sequencing
      7. Transcription Mediated Amplification
      8. Others
    5. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Diagnostics Laboratories
      4. Research Institutes
    6. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    7. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
  8. Europe Infectious Disease Molecular Diagnostics Market Size Analysis
    1. Introduction
    2. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Reagents
      3. Services
    3. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Respiratory Diseases
      2. Tuberculosis
      3. Meningitis
      4. Gastrointestinal Tract Infections
      5. HPV
      6. Sexually Transmitted Infections
      7. Sepsis
      8. Drug Resistance Disease
      9. Other Infectious Diseases
    4. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase chain reaction (PCR)
      2. In Situ Hybridization
      3. Isothermal Nucleic Acid Amplification Technology (INAAT)
      4. Chips and Microarrays
      5. Mass Spectrometry
      6. Sequencing
      7. Transcription Mediated Amplification
      8. Others
    5. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Diagnostics Laboratories
      4. Research Institutes
    6. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    7. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    8. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    9. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    10. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    11. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    12. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    13. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    14. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
  9. APAC Infectious Disease Molecular Diagnostics Market Size Analysis
    1. Introduction
    2. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Reagents
      3. Services
    3. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Respiratory Diseases
      2. Tuberculosis
      3. Meningitis
      4. Gastrointestinal Tract Infections
      5. HPV
      6. Sexually Transmitted Infections
      7. Sepsis
      8. Drug Resistance Disease
      9. Other Infectious Diseases
    4. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase chain reaction (PCR)
      2. In Situ Hybridization
      3. Isothermal Nucleic Acid Amplification Technology (INAAT)
      4. Chips and Microarrays
      5. Mass Spectrometry
      6. Sequencing
      7. Transcription Mediated Amplification
      8. Others
    5. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Diagnostics Laboratories
      4. Research Institutes
    6. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    7. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    8. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    9. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    10. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    11. Singapore
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    12. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    13. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    14. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
  10. Middle East and Africa Infectious Disease Molecular Diagnostics Market Size Analysis
    1. Introduction
    2. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Reagents
      3. Services
    3. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Respiratory Diseases
      2. Tuberculosis
      3. Meningitis
      4. Gastrointestinal Tract Infections
      5. HPV
      6. Sexually Transmitted Infections
      7. Sepsis
      8. Drug Resistance Disease
      9. Other Infectious Diseases
    4. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase chain reaction (PCR)
      2. In Situ Hybridization
      3. Isothermal Nucleic Acid Amplification Technology (INAAT)
      4. Chips and Microarrays
      5. Mass Spectrometry
      6. Sequencing
      7. Transcription Mediated Amplification
      8. Others
    5. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Diagnostics Laboratories
      4. Research Institutes
    6. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    7. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    8. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    9. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    10. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    11. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    12. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
  11. LATAM Infectious Disease Molecular Diagnostics Market Size Analysis
    1. Introduction
    2. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Instruments
      2. Reagents
      3. Services
    3. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
      1. Respiratory Diseases
      2. Tuberculosis
      3. Meningitis
      4. Gastrointestinal Tract Infections
      5. HPV
      6. Sexually Transmitted Infections
      7. Sepsis
      8. Drug Resistance Disease
      9. Other Infectious Diseases
    4. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
      1. Polymerase chain reaction (PCR)
      2. In Situ Hybridization
      3. Isothermal Nucleic Acid Amplification Technology (INAAT)
      4. Chips and Microarrays
      5. Mass Spectrometry
      6. Sequencing
      7. Transcription Mediated Amplification
      8. Others
    5. Infectious Disease Molecular Diagnostics Market Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Clinics
      3. Diagnostics Laboratories
      4. Research Institutes
    6. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    7. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    8. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    9. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    10. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
    11. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagents
        3. Services
      3. Market Size & Forecast By Applications 2022-2034 (USD MILLION/ Units)
        1. Respiratory Diseases
        2. Tuberculosis
        3. Meningitis
        4. Gastrointestinal Tract Infections
        5. HPV
        6. Sexually Transmitted Infections
        7. Sepsis
        8. Drug Resistance Disease
        9. Other Infectious Diseases
      4. Market Size & Forecast By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase chain reaction (PCR)
        2. In Situ Hybridization
        3. Isothermal Nucleic Acid Amplification Technology (INAAT)
        4. Chips and Microarrays
        5. Mass Spectrometry
        6. Sequencing
        7. Transcription Mediated Amplification
        8. Others
      5. Market Size & Forecast By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
  12. Competitive Landscape
    1. Infectious Disease Molecular Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Abbott
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Becton, Dickinson and Company
    3. biome Rieux SA
    4. Bio-Rad Laboratories, Inc.
    5. Agilent Technologies, Inc.
    6. Danaher Corporation
    7. Hologic, Inc. (Gen-Probe)
    8. Illumina, Inc.
    9. Grifols S.A.
    10. Qiagen
    11. F. Hoffmann-La Roche Ltd
    12. Siemens Healthiness AG
    13. Sysmex Corporation
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.